Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells

BACKGROUND: A malfunction of RXRα due to phosphorylation is associated with liver carcinogenesis, and acyclic retinoid (ACR), which targets RXRα, can prevent the development of hepatocellular carcinoma (HCC). Activation of PI3K/Akt signaling plays a critical role in the proliferation and survival of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Baba, Atsushi, Shimizu, Masahito, Ohno, Tomohiko, Shirakami, Yohei, Kubota, Masaya, Kochi, Takahiro, Terakura, Daishi, Tsurumi, Hisashi, Moriwaki, Hisataka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3852533/
https://ncbi.nlm.nih.gov/pubmed/24103747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-465
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak